Skip to content

The efficacy of Ketamine on treatment-resistant depression's symptoms

The efficacy comparison of single-dose vs. multi-dose of Ketamine on treatment-resistant depression's symptoms; a non-inferiority RCT study

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210125050137N1
Enrollment
30
Registered
2021-02-06
Start date
2021-02-19
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Resistant depression. Major depressive disorder, recurrent, unspecified

Interventions

Intervention 1: In the first intervention group: patients are treated with a single dose of ketamine. In this group, ketamine is received only once, 50 cc of normal saline, which contains 0.5 mg per k

Sponsors

Kashan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Males and females, aged 18 -65 years old DSM-V Major Depression Disorder diagnosis confirmed by The Hamilton Depression Rating Scale The patient has refractory depression, a type of major depression that has not responded to traditional treatment options and the first line of treatment and has taken at least 2 trials of antidepressant drug without sufficient response

Exclusion criteria

Exclusion criteria: Having other psychiatric illnesses other than major depression Having a history of one or more seizures for no apparent reason Pregnancy and lactation Bipolar disorder Having uncontrolled non-psychiatric illnesses, including cardiovascular disease Having a history of stimulant use during the last three months

Design outcomes

Primary

MeasureTime frame
Depression score based on Hamilton scale. Timepoint: Monthly. Method of measurement: Hamilton questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAfshin Ahmadvand

Kashan University of Medical Sciences

afshin.ahmadvand@gmail.com+98 31 5554 9111

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026